<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: ldl cholesterol</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>LDL cholesterol is a poor marker of heart health in patients with kidney disease</title>
   	 <description>LDL cholesterol is not a useful marker of heart disease risk in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The finding suggests that other measurements should be used to assess kidney disease patients' cardiovascular health.</description>
     <link>http://medicalxpress.com/news/2013-05-ldl-cholesterol-poor-marker-heart.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 16 May 2013 17:28:19 EST</pubDate>
	 <guid isPermaLink="false">news287944090</guid>
	 
</item>
<item>
     <title>Diabetes self-care improves slowly, US report finds</title>
   	 <description>(HealthDay)— More Americans are meeting diabetes care goals, but nearly half still aren't achieving major targets for controlling blood sugar, blood pressure and cholesterol,  government health officials say.</description>
     <link>http://medicalxpress.com/news/2013-04-diabetes-self-care-slowly.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 24 Apr 2013 18:20:01 EST</pubDate>
	 <guid isPermaLink="false">news286043637</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/diabetesself.jpg" width="90" height="90" />
</item>
<item>
     <title>Where does coffee stand in your health?</title>
   	 <description>We are often asked whether coffee is good or bad for the health. The answer is both good and bad.</description>
     <link>http://medicalxpress.com/news/2013-04-coffee-health.html</link>
	 <category>Health</category>
	 <pubDate>Sat, 13 Apr 2013 09:20:01 EST</pubDate>
	 <guid isPermaLink="false">news285049051</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2009/2-coffee.jpg" width="90" height="80" />
</item>
<item>
     <title>Commonly used cholesterol calculation underestimates heart disease danger for many</title>
   	 <description>In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein (LDL) cholesterol levels is often inaccurate. Of most concern, the researchers say, is their finding that the widely used formula underestimates LDL where accuracy matters most—in the range considered desirable for high-risk patients. Results of the study are published in an online article, ahead of print, in the Journal of the American College of Cardiology.</description>
     <link>http://medicalxpress.com/news/2013-03-commonly-cholesterol-underestimates-heart-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 26 Mar 2013 13:06:59 EST</pubDate>
	 <guid isPermaLink="false">news283522009</guid>
	 
</item>
<item>
     <title>Researchers find alternative cholesterol-lowering drug for patients who can't tolerate statins</title>
   	 <description>Heart patients who can't tolerate the side effects of cholesterol-lowering drugs may have a new option, according to a new study by researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City.</description>
     <link>http://medicalxpress.com/news/2013-03-alternative-cholesterol-lowering-drug-patients-tolerate.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 11 Mar 2013 13:04:50 EST</pubDate>
	 <guid isPermaLink="false">news282225884</guid>
	 
</item>
<item>
     <title>Niacin therapy unhelpful, occasionally harmful, study says</title>
   	 <description>A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.</description>
     <link>http://medicalxpress.com/news/2013-03-niacin-therapy-unhelpful-occasionally.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 09 Mar 2013 15:11:35 EST</pubDate>
	 <guid isPermaLink="false">news282064288</guid>
	 
</item>
<item>
     <title>High-fiber diet helps heart too, expert says</title>
   	 <description>(HealthDay)—Eating a high-fiber diet does more than promote digestive well-being; it's also good for your heart, an expert says.</description>
     <link>http://medicalxpress.com/news/2013-03-high-fiber-diet-heart-expert.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 03 Mar 2013 04:12:58 EST</pubDate>
	 <guid isPermaLink="false">news281506365</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/highfiberdie.jpg" width="90" height="90" />
</item>
<item>
     <title>Machine similar to dialysis removes cholesterol from blood</title>
   	 <description>Some patients are genetically prone to such dangerously high levels of cholesterol that no amount of diet, exercise and medications can reduce their cholesterol to safe levels.</description>
     <link>http://medicalxpress.com/news/2013-03-machine-similar-dialysis-cholesterol-blood.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 01 Mar 2013 11:20:05 EST</pubDate>
	 <guid isPermaLink="false">news281356867</guid>
	 
</item>
<item>
     <title>HPS2-THRIVE trial: Side-effects cause a quarter of heart patients to stop treatment</title>
   	 <description>The largest randomised study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined with statin treatment.</description>
     <link>http://medicalxpress.com/news/2013-02-hps2-thrive-trial-side-effects-quarter-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 26 Feb 2013 19:00:04 EST</pubDate>
	 <guid isPermaLink="false">news281124976</guid>
	 
</item>
<item>
     <title>Chemicals in cookware, carpets may raise arthritis risk in women</title>
   	 <description>(HealthDay)—In what researchers are calling a first, a new analysis suggests that the greater a woman's exposure to a type of common chemical compound called PFCs, the greater her risk for developing osteoarthritis.</description>
     <link>http://medicalxpress.com/news/2013-02-chemicals-cookware-carpets-arthritis-women.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 14 Feb 2013 12:40:02 EST</pubDate>
	 <guid isPermaLink="false">news280065230</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/chemicalsinc.jpg" width="90" height="90" />
</item>
<item>
     <title>Blood pressure, cholesterol most important indicators of heart disease risk in diabetics</title>
   	 <description>For people with diabetes, meeting the recommended guidelines for blood pressure and cholesterol is even more important than meeting the guidelines for blood sugar control in reducing the risk of heart attack or stroke, according to a new Kaiser Permanente study published today in the Journal of General Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-01-blood-pressure-cholesterol-important-indicators.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 28 Jan 2013 09:29:57 EST</pubDate>
	 <guid isPermaLink="false">news278587787</guid>
	 
</item>
<item>
     <title>Overlooked ugly cholesterol causes heart disease</title>
   	 <description>The risk of ischaemic heart disease – a disease affecting some 150,000 Danes – is three times higher in persons with high levels of the so-called 'ugly' cholesterol. This is the finding of a new study of 73,000 Danes, which is shedding light on a long debate on this topic. The results have just been published in the Journal of the American College of Cardiology.</description>
     <link>http://medicalxpress.com/news/2013-01-overlooked-ugly-cholesterol-heart-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 21 Jan 2013 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news277994802</guid>
	 
</item>
<item>
     <title>Letter from doctor boosts cholesterol medication use</title>
   	 <description>In a new study, Northwestern Medicine researchers found that patients at high risk for cardiovascular disease (CVD) are more likely to receive a prescription for cholesterol-lowering medication, and to achieve lower long-term cholesterol levels, when doctors use electronic health records (EHRs) to deliver personalized risk assessments via mail.</description>
     <link>http://medicalxpress.com/news/2012-11-letter-doctor-boosts-cholesterol-medication.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 15 Nov 2012 16:41:34 EST</pubDate>
	 <guid isPermaLink="false">news272220051</guid>
	 
</item>
<item>
     <title>New drug significantly lowers bad cholesterol</title>
   	 <description>For many people with high cholesterol, statins serve as the first line of treatment. However, some patients are unable to effectively reduce their low-density lipoprotein cholesterol (LDL cholesterol) or &quot;bad cholesterol&quot; levels with statins, the most commonly used medication to treat high cholesterol, due to their bodies' inability to tolerate or sufficiently respond to the medicine.</description>
     <link>http://medicalxpress.com/news/2012-11-drug-significantly-lowers-bad-cholesterol.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 06 Nov 2012 14:40:48 EST</pubDate>
	 <guid isPermaLink="false">news271435209</guid>
	 
</item>
<item>
     <title>New drug may help those who can't take statins</title>
   	 <description>(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.</description>
     <link>http://medicalxpress.com/news/2012-11-drug-statins.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 05 Nov 2012 17:21:20 EST</pubDate>
	 <guid isPermaLink="false">news271358446</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newdrugmayhe.jpg" width="90" height="90" />
</item>
<item>
     <title>Greater drop in LDL seen with atorvastatin plus PCSK9 antibody</title>
   	 <description>(HealthDay)—Addition of the fully human serum proprotein convertase subtilisin/kexin 9 monoclonal antibody, SAR236553, to atorvastatin is associated with greater reductions in low-density lipoprotein (LDL) cholesterol levels compared with atorvastatin alone, according to a study published online Oct. 31 in the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-11-greater-ldl-atorvastatin-pcsk9-antibody.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 02 Nov 2012 13:10:01 EST</pubDate>
	 <guid isPermaLink="false">news271078015</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/greaterdropi.jpg" width="90" height="96" />
</item>
<item>
     <title>Experts recommend screening adults for hypertriglyceridemia every five years</title>
   	 <description>The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of hypertriglyceridemia. Triglycerides are a type of fat found in the blood and are associated with cardiovascular risk. The CPG, entitled &quot;Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline&quot; appears in the September 2012 issue of the Journal of Clinical Endocrinology and Metabolism (JCEM), a publication of The Endocrine Society.</description>
     <link>http://medicalxpress.com/news/2012-09-experts-screening-adults-hypertriglyceridemia-years.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 07 Sep 2012 13:26:08 EST</pubDate>
	 <guid isPermaLink="false">news266243103</guid>
	 
</item>
<item>
     <title>Some improvement in heart risk factors for Americans: CDC</title>
   	 <description>(HealthDay) -- About 47 percent of American adults have at least one risk factor for heart disease, according to a new report released Friday.</description>
     <link>http://medicalxpress.com/news/2012-08-heart-factors-americans-cdc.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 03 Aug 2012 11:50:04 EST</pubDate>
	 <guid isPermaLink="false">news263212160</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/someimprovem.jpg" width="90" height="90" />
</item>
<item>
     <title>Low 'bad' cholesterol levels may be linked to cancer risk</title>
   	 <description>(HealthDay) -- There may be a link between low levels of &quot;bad&quot; low-density lipoprotein (LDL) cholesterol and increased cancer risk, according to new research.</description>
     <link>http://medicalxpress.com/news/2012-03-bad-cholesterol-linked-cancer.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 26 Mar 2012 08:10:02 EST</pubDate>
	 <guid isPermaLink="false">news251957292</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/lowbadcholes.jpg" width="90" height="90" />
</item>
<item>
     <title>Statin alternative looks promising in early trials</title>
   	 <description>(HealthDay) -- Administration of REGN727, a monoclonal antibody to proprotein convertase subtilisin/kexin 9 (PCSK9), significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to the results of three phase 1 studies published in the March 22 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-03-regn727-monoclonal-antibody-lowers-ldl.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 22 Mar 2012 04:49:03 EST</pubDate>
	 <guid isPermaLink="false">news251610535</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/regn727monoc.jpg" width="90" height="90" />
</item>
<item>
     <title>Soy-based S-equol supplement reduces metabolic syndrome risk factors</title>
   	 <description>A 12-week treatment of the fermented soy germ-based nutritional supplement containing S-equol significantly lowered hemoglobin A1c (HbA1c), LDL cholesterol and improved vascular stiffness, all factors that occur as part of metabolic syndrome, according to a first-of-its-kind peer-reviewed study reported in a poster at the Women's Health 2012 annual meeting.</description>
     <link>http://medicalxpress.com/news/2012-03-soy-based-s-equol-supplement-metabolic-syndrome.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 19 Mar 2012 10:31:21 EST</pubDate>
	 <guid isPermaLink="false">news251371859</guid>
	 
</item>
<item>
     <title>With mutation, you can have your cream and eat it, too</title>
   	 <description>People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way.</description>
     <link>http://medicalxpress.com/news/2011-12-mutation-cream.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 06 Dec 2011 13:10:01 EST</pubDate>
	 <guid isPermaLink="false">news242399378</guid>
	 
</item>
<item>
     <title>Heart disease: Long-term study proves benefit of statins</title>
   	 <description>Statins safely reduce the risk of cardiovascular illness even years after treatment is stopped, according to a probe into the popular cholesterol-busters published on Wednesday.</description>
     <link>http://medicalxpress.com/news/2011-11-heart-disease-long-term-benefit-statins.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 23 Nov 2011 05:22:24 EST</pubDate>
	 <guid isPermaLink="false">news241248125</guid>
	 
</item>
<item>
     <title>Niacin does not reduce heart attack, stroke risk in stable CV patients</title>
   	 <description>In patients whose bad cholesterol is very well-controlled by statins for a long time period, the addition of high-dose, extended release niacin did not reduce the risk of cardiovascular events, including heart attack and stroke.</description>
     <link>http://medicalxpress.com/news/2011-11-niacin-heart-stable-cv-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 15 Nov 2011 11:06:17 EST</pubDate>
	 <guid isPermaLink="false">news240576281</guid>
	 
</item>
<item>
     <title>Women undergoing PCI display greater number of co-morbidities than men</title>
   	 <description>New research shows that women undergoing percutaneous coronary intervention (PCI), also known as angioplasty, exhibit more co-morbidities and cardiovascular risk factors than men. Risk-adjusted analyses have now indicated that, in the contemporary era, gender is not an independent mortality predictor following PCI according to the study now available in Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).</description>
     <link>http://medicalxpress.com/news/2011-11-women-pci-greater-co-morbidities-men.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 01 Nov 2011 04:48:54 EST</pubDate>
	 <guid isPermaLink="false">news239341727</guid>
	 
</item>
<item>
     <title>Obama 'fit at fifty': medical report</title>
   	 <description> US President Barack Obama is &quot;fit at fifty&quot; after improving his cholesterol readings and kicking his smoking habit, according to results of his latest medical exam released Monday.</description>
     <link>http://medicalxpress.com/news/2011-10-obama-fifty-medical.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 31 Oct 2011 18:42:16 EST</pubDate>
	 <guid isPermaLink="false">news239305330</guid>
	 
</item>
<item>
     <title>First joint ESC/EAS guidelines for the management of dyslipidaemias</title>
   	 <description>Cardiovascular disease (CVD), driven by the global pandemics of obesity and diabetes, poses a daunting challenge to clinicians in the 21st century. Despite progress, there is still much to be done to improve the control of dyslipidaemia, a key risk factor. In Europe, as many as one-half of patients are inadequately treated.1,2 The first European guidelines specifically focused on managing dyslipidaemias offer new hope.3,4 Experts from the European Atherosclerosis Society (EAS) and the European Society of Cardiology (ESC) worked together to develop these guidelines. The aim was to keep pace with emerging data and provide up to date treatment advice for a wide range of dyslipidaemias, including diabetes and metabolic syndrome.</description>
     <link>http://medicalxpress.com/news/2011-06-joint-esceas-guidelines-dyslipidaemias.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 28 Jun 2011 07:42:44 EST</pubDate>
	 <guid isPermaLink="false">news228465631</guid>
	 
</item>


</channel>
</rss>
